Evidence map›Paper›PMID 26161005›Full record

ArticleMediators of inflammation2015

Prophylactic Ozone Administration Reduces Intestinal Mucosa Injury Induced by Intestinal Ischemia-Reperfusion in the Rat.

Ozkan Onal, Fahri Yetisir, A Ebru Salman Sarer, N Dilara Zeybek, C Oztug Onal, Banu Yurekli, H Tugrul Celik, Ayse Sirma, Mehmet Kılıc

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Is the increased ozone dosage key factor for its anti-inflammatory effect in an experimental model of mesenteric ischemia?Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023
    Article
  7. Article
  8. Evaluation of targeted oxidative stress induced by oxygen-ozoneRedox report : communications in free radical research · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Application of ozone therapy in interventional medicine.Journal of interventional medicine · 2019
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ozkan OnalDepartment of Anesthesiology and Reanimation, Selçuk University Medical Faculty, 42100 Konya, Turkey.
Fahri YetisirDepartment of General Surgery, Atatürk Education and Research Hospital, 06600 Ankara, Turkey.
A Ebru Salman SarerDepartment of Anesthesiology and Reanimation, Atatürk Education and Research Hospital, 06600 Ankara, Turkey.
N Dilara ZeybekDepartment of Histology and Embryology, Hacettepe University Faculty of Medicine, 06012 Ankara, Turkey.
C Oztug OnalAnkara 4th Tuberculosis Dispensary, 06021 Ankara, Turkey.
Banu YurekliDepartment of Endocrinology, Bozyaka Education and Research Hospital, 35022 İzmir, Turkey.
H Tugrul CelikDepartment of Biochemistry, Turgut Özal University Medical Faculty, 06010 Ankara, Turkey.
Ayse SirmaDepartment of Histology and Embryology, Hacettepe University Faculty of Medicine, 06012 Ankara, Turkey.
Mehmet KılıcDepartment of General Surgery, Atatürk Education and Research Hospital, 06600 Ankara, Turkey.
Hacettepe University · TRIzmir Bozyaka Eğitim ve Araştırma Hastanesi · TRSelçuk University · TRTurgut Özal University · TRTürk Anesteziyoloji ve Reanimasyon Derneği · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIntestinal ischemia-reperfusion injury is associated with mucosal damage and has a high rate of mortality. Various beneficial effects of ozone have been shown. The aim of the present study was to show the effects of ozone in ischemia reperfusion model in intestine. MATERIAL AND

methodTwenty eight Wistar rats were randomized into four groups with seven rats in each group. Control group was administered serum physiologic (SF) intraperitoneally (ip) for five days. Ozone group was administered 1 mg/kg ozone ip for five days. Ischemia Reperfusion (IR) group underwent superior mesenteric artery occlusion for one hour and then reperfusion for two hours. Ozone + IR group was administered 1 mg/kg ozone ip for five days and at sixth day IR model was applied. Rats were anesthetized with ketamine∖xyzlazine and their intracardiac blood was drawn completely and they were sacrificed. Intestinal tissue samples were examined under light microscope. Levels of superoxide dismutase (SOD), catalase (CAT), glutathioneperoxidase (GSH-Px), malondyaldehide (MDA), and protein carbonyl (PCO) were analyzed in tissue samples. Total oxidant status (TOS), and total antioxidant capacity (TAC) were analyzed in blood samples. Data were evaluated statistically by Kruskal Wallis test.

resultsIn the ozone administered group, degree of intestinal injury was not different from the control group. IR caused an increase in intestinal injury score. The intestinal epithelium maintained its integrity and decrease in intestinal injury score was detected in Ozone + IR group. SOD, GSH-Px, and CAT values were high in ozone group and low in IR. TOS parameter was highest in the IR group and the TAC parameter was highest in the ozone group and lowest in the IR group.

conclusionIn the present study, IR model caused an increase in intestinal injury.In the present study, ozone administration had an effect improving IR associated tissue injury. In the present study, ozone therapy prevented intestine from ischemia reperfusion injury. It is thought that the therapeutic effect of ozone is associated with increase in antioxidant enzymes and protection of cells from oxidation and inflammation.

Indexed as

AnimalsAntioxidantsIntestinal MucosaMaleOxidative StressOzoneRatsRats, WistarReperfusion InjuryAntioxidantsOzone

Identifiers

PMID26161005
PMCPMC4487723
OpenAlexW2157166559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.